X0508 4 2023-08-28 0001566469 NantHealth, Inc. NH 0001189020 SOON-SHIONG PATRICK C/O NANTHEALTH, INC. 760 FIRE TOWER RD, SUITE 107 WINTERVILLE NC 28590 true true true false Chief Executive Officer 0001517764 CALIFORNIA CAPITAL EQUITY, LLC C/O NANT CAPITAL, LLC 450 DULEY ROAD EL SEGUNDO CA 90245 false false true false 0001675760 NantWorks, LLC C/O NANT CAPITAL, LLC. 450 DULEY ROAD EL SEGUNDO CA 90245 false false true false 0001675758 Nant Capital, LLC 450 DULEY ROAD EL SEGUNDO CA 90245 false false true false false Common Stock 2023-08-28 4 P false 15384616 0.39 A 15384616 I See Footnote Common Stock 2023-08-28 4 P false 537272 18.6125 A 15921888 I See Footnote Common Stock 4453507 I See Footnote Shares of common stock, par value $0.0001 per share ("Common Stock"), acquired from the issuer pursuant to a Stock Purchase Agreement (the "Purchase Agreement"), dated as of August 28, 2023, by and between the issuer and certain institutional and accredited investors, each as listed as signatories to the Purchase Agreement. Shares held by Nant Capital, LLC ("Nant Capital"). California Capital Equity, LLC ("CalCap") directly owns all of the equity interests of Nant Capital and CalCap may be deemed to have beneficial ownership of the shares held by Nant Capital. Patrick Soon-Shiong directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap. $10,000,000 aggregate principal amount of the demand promissory note, dated January 4, 2016, as amended and restated on May 9, 2016 and April 27, 2021, respectively, by and between the issuer and Nant Capital (the "Subordinated Nant Capital Promissory Note"), were exchanged for shares of Common Stock in accordance with the terms and conditions of the Subordinated Nant Capital Promissory Note. Includes (i) 4,147,469 shares of our common stock held by NantWorks, LLC; (ii) 193,426 shares of our common stock held by NantOmics, LLC; and (iii) 112,612 shares of our common stock held by Cambridge Equities, LP. NantWorks, LLC is the largest member of NantOmics, LLC, holding approximately 84% of the outstanding equity and approximately 99% of the outstanding voting equity. Dr. Patrick Soon-Shiong, is the controlling member of NantWorks, LLC with voting and dispositive power over the shares of the stock held by NantWorks, LLC. Dr. Patrick Soon-Shiong, indirectly owns all of the equity interests in NantWorks, LLC and Cambridge Equities, LP, and has voting and dispositive powers over the shares. On December 15, 2022, the issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split") of its outstanding shares of Common Stock. The numbers of shares of Common Stock reported on this Form 4 have been adjusted to reflect the Reverse Split unless otherwise noted. /s/ Charles Kenworthy, Manager, Nant Capital, LLC 2023-08-30 /s/ Charles Kenworthy, Manager, California Capital Equity, LLC 2023-08-30 /s/ Patrick Soon-Shiong 2023-08-30